| Trial ID: | L2622 |
| Source ID: | NCT00144144
|
| Associated Drug: |
Angiotensin Ii Receptor Antagonists, Calcium Channel Blocker
|
| Title: |
A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hypertension|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Angiotensin II receptor antagonists, Calcium channel blocker
|
| Outcome Measures: |
Primary: Changes in blood pressure level at home after getting up.|The rate of the blood pressure levels at home after getting up, which effected the target levels (systolic blood pressure < 125 mm Hg, diastolic blood pressure < 80 mm Hg).|Adverse events, adverse drug reactions|Clinical laboratory data | Secondary: Changes in blood pressure levels measured on an outpatient basis.|The rate of the blood pressure levels measured on an outpatient basis, which effected the standard levels (systolic blood pressure level <130 mm Hg, diastolic blood pressure level < 80 mm Hg).|Changes in blood pressure levels measured at home before going to bed· Changes in IMT of the cervical artery|Changes in PWV· Changes in echocardiographic findings|Changes in urinary albumin level|Changes in BNP· Changes in hs-CRP· Medical cost-effectiveness
|
| Sponsor/Collaborators: |
Sponsor: Advanced-J | Collaborators: Japan Heart Foundation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
300
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-09
|
| Completion Date: |
2008-09
|
| Results First Posted: |
|
| Last Update Posted: |
2006-07-14
|
| Locations: |
Dept. of Clinical Immunology, Clinical Bioinformatics Research Unit, Graduate School of Medicine, the University of Tokyo, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT00144144
|
